Positron emission tomography imaging as a cancer biomarker
Related Experiment Video
Updated: Jul 11, 2026

A Basic Positron Emission Tomography System Constructed to Locate a Radioactive Source in a Bi-dimensional Space
Published on: February 1, 2016
1Seattle Cancer Care Alliance, Division of Medical Oncology, 825 Eastlake Avenue East, G4-836, Seattle, WA 98109, USA. evanyu@u.washington.edu
Abstract:
The practice of oncology is changing, with novel biologic agents broadening our therapeutic armamentarium. Along with excitement and promise, multiple new challenges arise. The concept of 'individualized cancer care,' where therapies are selected based on the unique characteristics of a patient's tumor, is gaining favor as an approach to address the heterogeneity of cancer. As a result, we must strive to discover biomarkers with prognostic and predictive value to improve drug selection, alteration and development. Metabolic and molecular imaging with PET appears at the forefront of this critical field. In this review, we discuss cancer biomarker development, opportunities for PET to elucidate tumor biology and the potential role of PET in clinical research and practice.
Insights
Novel biologic agents are transforming oncology, necessitating new biomarkers for individualized cancer care. Positron Emission Tomography (PET) imaging shows promise in discovering these biomarkers to guide targeted therapies and improve patient outcomes.
Area of Science:
- Oncology
- Biomarker Discovery
- Molecular Imaging
Background:
- The practice of oncology is evolving with the introduction of novel biologic agents.
- Cancer treatment is shifting towards individualized care, driven by tumor heterogeneity.
- There is a critical need for biomarkers to guide personalized therapeutic strategies.
Purpose of the Study:
- To review the development of cancer biomarkers.
- To explore the role of Positron Emission Tomography (PET) in elucidating tumor biology.
- To discuss the potential clinical applications of PET in cancer research and practice.
Main Methods:
- Review of current literature on cancer biomarker development.
- Discussion of metabolic and molecular imaging techniques, particularly PET.
- Analysis of the utility of PET in understanding tumor characteristics.
Main Results:
- Biomarker discovery is essential for advancing individualized cancer therapy.
- PET imaging offers significant opportunities to reveal critical aspects of tumor biology.
- PET has the potential to enhance drug development and clinical decision-making.
Conclusions:
- Individualized cancer care requires robust biomarker identification.
- PET imaging is a powerful tool for biomarker discovery and tumor characterization.
- Integrating PET into clinical research and practice can optimize cancer treatment strategies.
More Related Videos
Related Concept Videos
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

